Skip to content
10-Q

Quarterly Report

Amylyx Pharmaceuticals, Inc. AMLX

0001193125-25-174948

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 28, 2025 89.17M sh
Shares Diluted Q2 2025 · Jun 30, 2025 89.14M sh
Shares Diluted Q2 2025 · Jun 30, 2025 87.43M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.02M sh
Shares Diluted Q2 2025 · Jun 30, 2024 67.94M sh
Capex Q2 2025 · Jun 30, 2025 $28K
Capex Q2 2025 · Jun 30, 2024 $156K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$65.07M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$67.07M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $58.09M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $77.39M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $75M
Stockholders Equity Q2 2025 · Jun 30, 2025 $167.88M
Stockholders Equity Q2 2025 · Mar 31, 2025 $201.42M
Stockholders Equity Q2 2025 · Dec 31, 2024 $164.77M
Stockholders Equity Q2 2025 · Jun 30, 2024 $261.31M
Stockholders Equity Q2 2025 · Mar 31, 2024 $324.44M
Stockholders Equity Q2 2025 · Dec 31, 2023 $433.43M
Current Liabilities Q2 2025 · Jun 30, 2025 $21.42M
Current Liabilities Q2 2025 · Dec 31, 2024 $28.41M
Total Liabilities Q2 2025 · Jun 30, 2025 $26.72M
Total Liabilities Q2 2025 · Dec 31, 2024 $28.87M
Current Assets Q2 2025 · Jun 30, 2025 $186.89M
Current Assets Q2 2025 · Dec 31, 2024 $189.43M
Total Assets Q2 2025 · Jun 30, 2025 $194.6M
Total Assets Q2 2025 · Dec 31, 2024 $193.63M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.88
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.07
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.82
Eps Basic Q2 2025 · Jun 30, 2025 −$0.46
Eps Basic Q2 2025 · Jun 30, 2025 −$0.88
Eps Basic Q2 2025 · Jun 30, 2024 −$1.07
Eps Basic Q2 2025 · Jun 30, 2024 −$2.82
Sga Expense Q2 2025 · Jun 30, 2025 $15.64M
Sga Expense Q2 2025 · Jun 30, 2025 $31.32M
Sga Expense Q2 2025 · Jun 30, 2024 $21.65M
Sga Expense Q2 2025 · Jun 30, 2024 $79.41M
Rd Expense Q2 2025 · Jun 30, 2025 $27.22M
Rd Expense Q2 2025 · Jun 30, 2025 $49.34M
Rd Expense Q2 2025 · Jun 30, 2024 $23.35M
Rd Expense Q2 2025 · Jun 30, 2024 $59.96M
Net Income Q2 2025 · Jun 30, 2025 −$41.44M
Net Income Q2 2025 · Jun 30, 2025 −$77.35M
Net Income Q2 2025 · Mar 31, 2025 −$35.91M
Net Income Q2 2025 · Jun 30, 2024 −$72.7M
Net Income Q2 2025 · Jun 30, 2024 −$191.49M
Net Income Q2 2025 · Mar 31, 2024 −$118.79M
Operating Income Q2 2025 · Jun 30, 2025 −$42.86M
Operating Income Q2 2025 · Jun 30, 2025 −$80.66M
Operating Income Q2 2025 · Jun 30, 2024 −$76.29M
Operating Income Q2 2025 · Jun 30, 2024 −$198.42M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2024 $8K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $5.95M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 −$1.02M
Revenue Q2 2025 · Jun 30, 2024 $87.62M